233 related articles for article (PubMed ID: 23094755)
21. Recommendations for liver biopsy evaluation in non-alcoholic fatty liver disease.
Stinton LM; Loomba R
Minerva Gastroenterol Dietol; 2014 Mar; 60(1):5-13. PubMed ID: 24632764
[TBL] [Abstract][Full Text] [Related]
22. Epidemiology and natural history of non-alcoholic fatty liver disease.
Fazel Y; Koenig AB; Sayiner M; Goodman ZD; Younossi ZM
Metabolism; 2016 Aug; 65(8):1017-25. PubMed ID: 26997539
[TBL] [Abstract][Full Text] [Related]
23. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study.
Williams CD; Stengel J; Asike MI; Torres DM; Shaw J; Contreras M; Landt CL; Harrison SA
Gastroenterology; 2011 Jan; 140(1):124-31. PubMed ID: 20858492
[TBL] [Abstract][Full Text] [Related]
24. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults.
Vernon G; Baranova A; Younossi ZM
Aliment Pharmacol Ther; 2011 Aug; 34(3):274-85. PubMed ID: 21623852
[TBL] [Abstract][Full Text] [Related]
25. Histopathological stages of nonalcoholic fatty liver disease in type 2 diabetes: prevalences and correlated factors.
Leite NC; Villela-Nogueira CA; Pannain VL; Bottino AC; Rezende GF; Cardoso CR; Salles GF
Liver Int; 2011 May; 31(5):700-6. PubMed ID: 21457442
[TBL] [Abstract][Full Text] [Related]
26. Nonalcoholic fatty liver disease: from steatosis to cirrhosis.
Farrell GC; Larter CZ
Hepatology; 2006 Feb; 43(2 Suppl 1):S99-S112. PubMed ID: 16447287
[TBL] [Abstract][Full Text] [Related]
27. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with nonalcoholic fatty liver disease (NAFLD).
Yoneda M; Yoneda M; Mawatari H; Fujita K; Endo H; Iida H; Nozaki Y; Yonemitsu K; Higurashi T; Takahashi H; Kobayashi N; Kirikoshi H; Abe Y; Inamori M; Kubota K; Saito S; Tamano M; Hiraishi H; Maeyama S; Yamaguchi N; Togo S; Nakajima A
Dig Liver Dis; 2008 May; 40(5):371-8. PubMed ID: 18083083
[TBL] [Abstract][Full Text] [Related]
28. What are the risk factors and settings for non-alcoholic fatty liver disease in Asia-Pacific?
Fan JG; Saibara T; Chitturi S; Kim BI; Sung JJ; Chutaputti A;
J Gastroenterol Hepatol; 2007 Jun; 22(6):794-800. PubMed ID: 17498218
[TBL] [Abstract][Full Text] [Related]
29. Non invasive indexes for the assessment of patients with non-alcoholic fatty liver disease.
Petta S; Handberg A; Craxì A
Curr Pharm Des; 2013; 19(29):5193-218. PubMed ID: 23394090
[TBL] [Abstract][Full Text] [Related]
30. Prevalence and Severity of Nonalcoholic Fatty Liver Disease Among Caregivers of Patients With Nonalcoholic Fatty Liver Disease Cirrhosis.
Siddiqui MS; Carbone S; Vincent R; Patel S; Driscoll C; Celi FS; Billingsley H; Rotelli B; John B; Potere N; Viscusi M; Adiletta V; Sanyal AJ; Luketic VA; Reichman T; Bhati CS
Clin Gastroenterol Hepatol; 2019 Sep; 17(10):2132-2133. PubMed ID: 30448600
[TBL] [Abstract][Full Text] [Related]
31. Cardiovascular disease and nonalcoholic fatty liver disease: does histologic severity matter?
Domanski JP; Park SJ; Harrison SA
J Clin Gastroenterol; 2012; 46(5):427-30. PubMed ID: 22469639
[TBL] [Abstract][Full Text] [Related]
32. Liver fibrosis markers of nonalcoholic steatohepatitis.
Enomoto H; Bando Y; Nakamura H; Nishiguchi S; Koga M
World J Gastroenterol; 2015 Jun; 21(24):7427-35. PubMed ID: 26139988
[TBL] [Abstract][Full Text] [Related]
33. Steatohepatitis and liver fibrosis are predicted by the characteristics of very low density lipoprotein in nonalcoholic fatty liver disease.
Jiang ZG; Tapper EB; Connelly MA; Pimentel CF; Feldbrügge L; Kim M; Krawczyk S; Afdhal N; Robson SC; Herman MA; Otvos JD; Mukamal KJ; Lai M
Liver Int; 2016 Aug; 36(8):1213-20. PubMed ID: 26815314
[TBL] [Abstract][Full Text] [Related]
34. Serum cytokeratin-18 fragment levels as noninvasive marker of nonalcoholic steatohepatitis in the chilean population.
Arab JP; Hernández-Rocha C; Morales C; Vargas JI; Solís N; Pizarro M; Robles C; Sandoval D; Ponthus S; Benítez C; Barrera F; Soza A; Riquelme A; Arrese M
Gastroenterol Hepatol; 2017; 40(6):388-394. PubMed ID: 28359548
[TBL] [Abstract][Full Text] [Related]
35. [Nonalcoholic fatty liver disease].
Lemoine M; Serfaty L
Presse Med; 2012 Feb; 41(2):169-89. PubMed ID: 21723084
[TBL] [Abstract][Full Text] [Related]
36. Evaluating the Relationship Between Metabolic Syndrome and Liver Biopsy-Proven Non-Alcoholic Steatohepatitis in China: A Multicenter Cross-Sectional Study Design.
Xu ZJ; Shi JP; Yu DR; Zhu LJ; Jia JD; Fan JG
Adv Ther; 2016 Nov; 33(11):2069-2081. PubMed ID: 27743352
[TBL] [Abstract][Full Text] [Related]
37. Nonalcoholic steatohepatitis.
Brunt EM
Semin Liver Dis; 2004 Feb; 24(1):3-20. PubMed ID: 15085483
[TBL] [Abstract][Full Text] [Related]
38. Diagnosis of nonalcoholic fatty liver disease: invasive versus noninvasive.
Wieckowska A; Feldstein AE
Semin Liver Dis; 2008 Nov; 28(4):386-95. PubMed ID: 18956295
[TBL] [Abstract][Full Text] [Related]
39. Clinical relevance of liver histopathology and different histological classifications of NASH in adults.
Nascimbeni F; Ballestri S; Machado MV; Mantovani A; Cortez-Pinto H; Targher G; Lonardo A
Expert Rev Gastroenterol Hepatol; 2018 Apr; 12(4):351-367. PubMed ID: 29224471
[TBL] [Abstract][Full Text] [Related]
40. Non-alcoholic fatty liver disease, obesity and the metabolic syndrome.
Dietrich P; Hellerbrand C
Best Pract Res Clin Gastroenterol; 2014 Aug; 28(4):637-53. PubMed ID: 25194181
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]